Fibroblast growth factor-2 (FGF-2) is overexpressed in human melanoma and may be induced by an increased release by tumor cells of matrix metalloproteinases (MMPs) which, in turn, degrade extracellular matrix inducing the release of FGF-2 stored there as an inactive form. The gene discussed is FGF2; the disease is neoplasm.